In the current month, CCRN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CCRN average Analyst price target in the last month is 12.150.
Based on analysts' estimates, CCRN EPS is projected to reach 0.010 in FY2026Q2, following reported EPS of -0.136 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.14, while Cross Country Healthcare IncCCRN's earnings per share (EPS) for the previous quarter was USD -2.56. EPS for the next quarter is expected at USD 0.01.